Analysed ABIVAX SA (AAVXF:OTCMKTS) News Sources
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update
16-07-2026
yahoo.com
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
23-07-2026
yahoo.com
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?
26-07-2026
yahoo.com
PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants
29-07-2026
yahoo.com
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
30-07-2026
yahoo.com
What is the current price of ABIVAX SA (AAVXF:OTCMKTS)?
The current price of ABIVAX SA (AAVXF:OTCMKTS) is $0.
ABIVAX SA (AAVXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ABIVAX SA (AAVXF:OTCMKTS) since the previous trading day is $None.
ABIVAX SA (AAVXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ABIVAX SA (AAVXF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for ABIVAX SA (AAVXF:OTCMKTS)?
The most recent average sentiment score for ABIVAX SA (AAVXF:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for ABIVAX SA (AAVXF:OTCMKTS)?
The most recent sentiment for ABIVAX SA (AAVXF:OTCMKTS) is .
SEC-8K** Filing Available For ABIVAX SA (AAVXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.